A single-dose gene therapy has shown promising results in terms of safety, efficacy, and patient-reported outcomes. The therapy is being used to treat hemophilia B, with outcomes indicating a potentially effective treatment. The treatment's safety and efficacy have been demonstrated, suggesting a positive impact on patients with this condition.